Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-04-18

Clinical Trial Update: Brief Intervention for OCD Fears [Phase 4]

View source ↗

Summary

Phase 4 clinical trial for Brief Intervention for OCD Fears has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Obsessive-compulsive Disorder | Phase 4 | Status: WITHDRAWN